BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36251932)

  • 1. Effects of multi-kinase inhibitors on the activity of cytochrome P450 2J2.
    Kojima A; Nadai M; Murayama N; Yamazaki H; Katoh M
    Xenobiotica; 2022 Jul; 52(7):669-675. PubMed ID: 36251932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors.
    Leow JWH; Verma RK; Lim ABH; Fan H; Chan ECY
    Eur J Pharm Sci; 2021 Sep; 164():105889. PubMed ID: 34044117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
    Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
    Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E; Wu Z; Shon JC; Liu KH
    Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes.
    Leow JWH; Gu Y; Chan ECY
    Eur J Pharm Sci; 2023 Aug; 187():106475. PubMed ID: 37225005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
    Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation.
    Park SH; Lee J; Shon JC; Phuc NM; Jee JG; Liu KH
    Phytomedicine; 2018 Mar; 42():199-206. PubMed ID: 29655687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.
    Ikemura N; Yamaori S; Kobayashi C; Kamijo S; Murayama N; Yamazaki H; Ohmori S
    Chem Biol Interact; 2019 Jun; 306():1-9. PubMed ID: 30965050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.
    Chen C; Wei X; Rao X; Wu J; Yang S; Chen F; Ma D; Zhou J; Dackor RT; Zeldin DC; Wang DW
    J Pharmacol Exp Ther; 2011 Feb; 336(2):344-55. PubMed ID: 21030485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
    Xu M; Ju W; Hao H; Wang G; Li P
    Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα
    He Z; Yang Y; Wen Z; Chen C; Xu X; Zhu Y; Wang Y; Wang DW
    J Lipid Res; 2017 Jul; 58(7):1338-1353. PubMed ID: 28554983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
    Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
    Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Cytochrome P450 2J2-Mediated Metabolism of Rivaroxaban and Arachidonic Acid by Ibrutinib and Osimertinib.
    Wang Z; Yong Chan EC
    Drug Metab Dispos; 2022 Oct; 50(10):1332-1341. PubMed ID: 35817438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
    Karkhanis A; Tram NDT; Chan ECY
    Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.
    Aliwarga T; Evangelista EA; Sotoodehnia N; Lemaitre RN; Totah RA
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2J2
    Tao P; Jiang Y; Wang H; Gao G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):932-941. PubMed ID: 34707002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
    Allison SE; Chen Y; Petrovic N; Zhang J; Bourget K; Mackenzie PI; Murray M
    Biochem Pharmacol; 2017 Nov; 143():79-89. PubMed ID: 28756208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM; Wu Z; O Y; Lee JH; Oh S; Song GY; Liu KH
    Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole.
    Matsumoto S; Hirama T; Matsubara T; Nagata K; Yamazoe Y
    Drug Metab Dispos; 2002 Nov; 30(11):1240-5. PubMed ID: 12386130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinant of substrate binding and specificity of cytochrome P450 2J2.
    Xu L; Chen LY
    Sci Rep; 2020 Dec; 10(1):22267. PubMed ID: 33335233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.